{
  "ticker": "NUC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972382",
  "id": "02972382",
  "pages": 8,
  "price_sensitive": true,
  "date": "20250724",
  "time": "1451",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m3g9259fj03w.pdf",
  "summary": "### **Summary of Nuchev Limited ASX Announcement (24 July 2025)**  \n\n#### **Quarterly Report (Appendix 4C) \u2013 Key Highlights:**  \n- **Revenue:**  \n  - **Q4 FY25 Group revenue:** $6.3m (+167% pcp, +17% QoQ).  \n  - **FY25 Group revenue:** $22.8m (+110% pcp).  \n  - **Practitioner channel sales (from bWellness acquisition):** $1.7m (Q4), $8.5m (FY25).  \n  - **Oli6\u00ae sales growth:**  \n    - ANZ retail: $1.7m (+32% pcp, +14% QoQ).  \n    - China CBEC: $2.3m (+114% pcp, +64% QoQ).  \n    - Vietnam: $0.6m (Q4), $1.6m (FY25).  \n\n- **Cash Position:**  \n  - **Closing cash (30 June 2025):** $3.6m.  \n  - **Net operating cash outflow:** $0.1m (vs. $1.1m in prior quarter).  \n\n- **Other Material Updates:**  \n  - **New Agency Agreement:** Signed with Brauer & H&S Brands (incremental $0.1m revenue in Q4).  \n  - **New Product Development (NPD):** Oli6\u00ae Grow launched, contributing $0.3m in Q4.  \n  - **Funding runway:** ~4.2 quarters based on current cash and facilities.  \n\n**No capital raising, trading halt, or other structural changes disclosed.**",
  "usage": {
    "prompt_tokens": 4977,
    "completion_tokens": 359,
    "total_tokens": 5336,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-24T06:05:06.906522"
}